2m 2m 2m 2m 2m 2m 2m
GPL Holdings (GPLL)
OTC
$0.01-$0.010 (-45.93%)
Price as of Sep 17, 2026- N/AMarket Cap
- 5,550.00%1-Year Change
- BiotechnologyIndustry
GPL Holdings (GPLL)
$0.01-$0.010 (-45.93%)
Annual
Quarterly
07/31/2023 | 07/31/2022 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | |
Total Operating Expenses | 62,743 +40.64% | 44,611 N/A | |
Operating Profit | -62,743 +40.64% | -44,611 N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | |
Income before Taxes | -62,743 +40.64% | -44,611 N/A | |
Income Taxes | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -62,743 +40.64% | -44,611 N/A | |
Net Income from Continuing Operations Applicable to Common | -62,743 +40.64% | -44,611 N/A | |
Basic EPS and Net Income | 0.00 N/A | N/A N/A | |
Diluted EPS and Net Income | 0.00 N/A | N/A N/A | |
Basic Weighted Average Shares | 176.3M N/A | N/A N/A | |
Diluted Weighted Average Shares | 176.3M N/A | N/A N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 10,014 N/A | N/A N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 10,014 N/A | 0 N/A | |
Total Current Assets | 10,014 N/A | N/A N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | |
Total Assets | 10,014 N/A | N/A N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | |
Total Current Liabilities | N/A N/A | N/A N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | |
Total Liabilities | 122,778 +145.45% | 50,021 N/A | |
Retained Earnings | -112,764 +125.43% | -50,021 N/A | |
Total Stockholders Equity | -112,764 +125.43% | -50,021 N/A | |
Total Shares Outstanding | 226.9M +28.71% | 176.3M N/A | |
Cash Flow | |||
Cash from Operating Activities | -62,743 +27.89% | -49,061 N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 72,757 +48.30% | 49,061 N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | N/A N/A | N/A N/A | |
Return on Equity | 77.09% N/A | N/A N/A | |
Revenue Growth | N/A N/A | N/A N/A | |
Current Ratio | N/A N/A | N/A N/A | |
Cash Ratio | N/A N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow